ELF3 emerges as a novel prognostic indicator implicated in gastric cancer progression and correlated with unfavorable clinical outcomes

Figure 4 Correlation between E74-like ETS transcription factor 3 expression and prognosis of stomach adenocarcinoma patients from the study population cohort. A: Immunohistochemistry images of E74-like ETS transcription factor 3 (ELF3) in stomach adenocarcinoma (STAD) and matched normal tissues; B: Expression was verified using the GEPIA database, and the results showed that ELF3 was overexpressed in STAD tissues; C and D: The expression of ELF3 was positively correlated with Ki-67 expression, and negatively correlated with E-cadherin expression; E: High ELF3 expression in STAD patients was related to worse survival. ^aP < 0.05. ELF3: E74-like ETS transcription factor 3; STAD: Stomach adenocarcinoma; OS: Overall survival.